RGC Regencell Bioscience
- 7.300
- +0.370+5.34%
Regencell Bioscience News
Regencell Bioscience | 20-F: FY2024 Annual Report
Regencell Bioscience | 6-K: Report of foreign private issuer (related to financial reporting)
Regencell Bioscience | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Regencell Bioscience | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Regencell Bioscience | 20-F: FY2023 Annual Report
Regencell Bioscience | 6-K: Report of foreign private issuer (related to financial reporting)
Regencell Bioscience | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Regencell Bioscience | 6-K: Report of foreign private issuer (related to financial reporting)
Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Regencell Bioscience | 20-F: FY2022 Annual Report
Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Regencell Bioscience | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Regencell (BVI) Limited(81.2%),Yat-Gai Au(81.2%)
Regencell Bioscience | 6-K: Report of foreign private issuer (related to financial reporting)
Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Regencell Bioscience | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Regencell (BVI) Limited(81.0%),Yat-Gai Au(81.0%)
Regencell Bioscience | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Regencell Bioscience | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Regencell (BVI) Limited(80.6%),Yat-Gai Au(80.6%)
Analysis
Price Target
No Data
No Data